美迪西上周获融资净买入5977.61万元，居两市第177位

Core Viewpoint - The financing activities of Shanghai Medicilon Inc. indicate a mixed performance in the market, with significant net inflows and outflows in recent weeks, reflecting investor sentiment and market dynamics [1]. Financing Data - Shanghai Medicilon received a net financing inflow of 59.7761 million yuan last week, ranking 177th in the market [1]. - The total financing amount for the week was 328 million yuan, while repayments amounted to 268 million yuan [1]. Capital Flow - Over the past 5 days, the main capital inflow for Shanghai Medicilon was 72.1846 million yuan, with a price increase of 2.76% during this period [1]. - In contrast, the company experienced a capital outflow of 107 million yuan over the last 10 days, resulting in a price decline of 2.42% [1]. Company Profile - Shanghai Medicilon was established in 2004 and is located in Shanghai, primarily engaged in the pharmaceutical manufacturing industry [1]. - The company has a registered capital of 1.34673 billion yuan, which is also its paid-in capital [1]. - The legal representative of the company is Chun-Lin Chen [1]. Investment and Intellectual Property - Shanghai Medicilon has invested in 9 companies and participated in 65 bidding projects [1]. - The company holds 10 trademark registrations and 74 patents, along with 322 administrative licenses [1].